Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003
Top Cited Papers
Open Access
- 3 November 2008
- Vol. 113 (S10) , 2883-2891
- https://doi.org/10.1002/cncr.23743
Abstract
BACKGROUND. Invasive squamous cell carcinoma (SCC) of the penis is rare in the United States. Although human papillomavirus (HPV) infection is an established etiologic agent in at least 40% of penile SCCs, relatively little is known about the epidemiology of this malignancy. METHODS. Population‐based data from the National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) program, the Centers for Disease Control and Prevention's National Program for Cancer Registries, and the National Center for Health Statistics were used to examine invasive penile SCC incidence and mortality in the United States. SEER data were used to examine treatment of penile SCC. RESULTS. From 1998 to 2003, 4967 men were diagnosed with histologically confirmed invasive penile SCC in the United States, representing less than 1% of new cancers in men. The annual, average age‐adjusted incidence rate was 0.81 cases per 100,000 men, and rates increased steadily with age. Overall, penile SCC incidence was comparable in whites and blacks, but approximately 2‐fold lower in Asians/Pacific Islanders. Rates among Hispanics were 72% higher compared with non‐Hispanics. Blacks compared with whites and Asians/Pacific Islanders and Hispanics compared with non‐Hispanics were diagnosed at significantly younger ages. Higher rates of mortality were also observed among blacks compared with whites and Hispanics compared with non‐Hispanics. Penile SCC incidence and mortality were elevated in Southern states and in regions of low socioeconomic status (SES). Some histologic and anatomic site differences were observed by race and ethnicity. Treatment of penile SCC varied with age, stage, and other tumor characteristics. CONCLUSIONS. There are considerable disparities in invasive penile cancer incidence and mortality in the United States. Key risk factors for excess incidence include Hispanic ethnicity and residence in the South and in low SES regions. Risks for excess mortality include these factors in addition to black race. Decreases in penile cancer incidence and mortality in the United States may be realized in the future as the indirect result of prophylactic HPV vaccination of females. Further research is needed to better understand the epidemiology of penile cancer including the role of HPV. Cancer 2008;113(10 suppl):2883–91. Published 2008 by the American Cancer Society.Keywords
This publication has 32 references indexed in Scilit:
- Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: Overview of methodsCancer, 2008
- Circumcision and Human Papillomavirus Infection in Men: A Site‐Specific ComparisonThe Journal of Infectious Diseases, 2008
- Demographic and Pathologic Differences in the Incidence of Invasive Penile Cancer in the United States, 1995-2003Cancer Epidemiology, Biomarkers & Prevention, 2007
- Prevalence of Circumcision and Herpes Simplex Virus Type 2 Infection in Men in the United States: The National Health and Nutrition Examination Survey (NHANES), 1999–2004Sexually Transmitted Diseases, 2007
- The prevalence of human papillomavirus genotypes in penile cancers from northern ThailandJournal of Medical Virology, 2006
- Chapter 2: The burden of HPV-related cancersVaccine, 2006
- Prevalence and determinants of human papillomavirus infection in men attending vasectomy clinics in MexicoInternational Journal of Cancer, 2006
- Penile cancerJournal of the American Academy of Dermatology, 2006
- Risk factors for genital HPV DNA in men resemble those found in women: a study of male attendees at a Danish STD clinicSexually Transmitted Infections, 2002
- History of Circumcision, Medical Conditions, and Sexual Activity and Risk of Penile CancerJNCI Journal of the National Cancer Institute, 1993